Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia

Haematologica. 2008 Jan;93(1):14-9. doi: 10.3324/haematol.12319.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / biosynthesis*
  • CpG Islands
  • Cytogenetic Analysis
  • Disease-Free Survival
  • Genetic Predisposition to Disease
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Medical Oncology / methods*
  • Models, Genetic
  • Pharmacogenetics
  • Prognosis
  • Treatment Outcome

Substances

  • Biomarkers, Tumor